MARKET

GENE

GENE

Genetic Technologies
NASDAQ
2.280
-0.010
-0.44%
Closed 16:00 05/17 EDT
OPEN
2.350
PREV CLOSE
2.290
HIGH
2.355
LOW
2.230
VOLUME
24.92K
TURNOVER
0
52 WEEK HIGH
5.90
52 WEEK LOW
1.800
MARKET CAP
10.05M
P/E (TTM)
-1.9086
1D
5D
1M
3M
1Y
5Y
Cannabis Stock Gainers And Losers From May 14, 2024
Aurora Cannabis shares closed up at $. Eastside Distilling shares closed down in the last week. The company's share price closed up in the past week. A number of other cannabis companies closed down in the same period of time.
Benzinga · 6d ago
Weekly Report: what happened at GENE last week (0506-0510)?
Weekly Report · 05/13 10:55
Bullish Monday For Marijuana Stocks - Target Group, Item 9 Labs Among Top Gainers
Target Group (OTC:CBDY) shares closed up 50.00% at $0.00. Heritage Cannabis Holding shares up 25.00%. Global Hemp Group shares closed down 31.67% in the last trading day. Other companies in the cannabis sector closed down as well.
Benzinga · 05/06 20:30
Weekly Report: what happened at GENE last week (0429-0503)?
Weekly Report · 05/06 11:01
Genetic Technologies Forges Major US Wellness Partnership
TipRanks · 05/06 10:59
Genetic Technologies And Wellworks For You Sign B2b Sales & Marketing Deal Covering 750 Employer Groups And 2M U.S. Employees
Genetic Technologies Limited announces a strategic joint sales & marketing agreement with Wellworks for You Inc. Wellworks will incorporate the geneType portfolio of tests into its employee wellness solutions for organizations in the U.S. The company is a global leader in genomics-based tests in health, wellness and serious disease.
Benzinga · 05/06 10:18
Genetic Technologies: Report of foreign issuer
Press release · 04/30 12:11
Genetic Technologies Reports Robust Growth and Expansion
TipRanks · 04/30 11:27
More
About GENE
Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company operates through three segments: EasyDNA, AffinityDNA, and GeneType / Corporate. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses. GeneType / Corporate segment relates to geneType branded test sales and expenses, including corporate charges. The GeneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and mor

Webull offers Genetic Technologies Limited (ADR) stock information, including NASDAQ: GENE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GENE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GENE stock methods without spending real money on the virtual paper trading platform.